Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.88B | 20.00B | 19.42B | 17.47B | 14.44B | 13.63B |
Gross Profit | 6.32B | 6.41B | 5.96B | 5.29B | 3.55B | 2.70B |
EBITDA | 2.95B | 3.36B | 3.07B | 2.98B | 1.57B | 1.11B |
Net Income | 1.08B | 1.09B | 1.06B | 897.87M | -434.38M | -972.79M |
Balance Sheet | ||||||
Total Assets | 56.49B | 56.42B | 56.67B | 56.79B | 56.69B | 57.46B |
Cash, Cash Equivalents and Short-Term Investments | 3.00B | 2.66B | 2.71B | 2.49B | 2.52B | 2.44B |
Total Debt | 26.33B | 26.68B | 27.76B | 29.48B | 30.66B | 31.53B |
Total Liabilities | 37.54B | 37.39B | 38.58B | 39.80B | 40.42B | 40.82B |
Stockholders Equity | 18.96B | 19.03B | 18.09B | 16.99B | 16.27B | 16.63B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.56B | 2.06B | 1.32B | 1.00B | -2.46B |
Operating Cash Flow | 0.00 | 2.57B | 2.88B | 2.68B | 2.14B | 509.02M |
Investing Cash Flow | 0.00 | -1.19B | -849.79M | -1.45B | -1.21B | -3.12B |
Financing Cash Flow | 0.00 | -1.43B | -1.82B | -1.25B | -855.22M | 3.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥13.26B | 7.62 | 0.30% | 2.97% | -16.90% | ||
72 Outperform | ¥7.99B | 7.35 | 0.48% | 2.99% | 2.07% | ||
65 Neutral | ¥18.64B | 16.16 | 0.86% | -0.82% | 12.28% | ||
64 Neutral | ¥18.98B | 13.72 | 1.28% | 10.64% | 110.16% | ||
64 Neutral | kr60.89B | 13.58 | 1.88% | 7.60% | 0.71% | -4.20% | |
63 Neutral | ¥43.20B | 8.39 | 2.84% | 0.92% | 55.82% | ||
51 Neutral | ¥3.00B | 25.97 | ― | 7.40% | 24.66% |